Save Stemcell Center ApS: Financial statements 2022
CVR: 39936119
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Save Stemcell Center ApS (CVR 39936119) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 85,332 and a net result of DKK -139,052 compared with DKK -428,771 the year before. That is a decrease of 84.2% compared with the year before. Equity in the 2022 report amounted to DKK -656,542.
- Gross Profit
- DKK 85,332
- Profit/Loss
- DKK -139,052
- Equity
- DKK -656,542
- Total Assets
- DKK 133,045
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 85 t. | -139 t. | -657 t. | 0 |
| 2021 | - | 542 t. | -429 t. | -517 t. | 1 |
| 2020 | - | 1.1 mio. | -205 t. | -89 t. | 1 |
Official annual report
Keep an eye on Save Stemcell Center ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Save Stemcell Center ApS has published its annual report for 2021. Gross profit came to DKK 541,518, and the net result was DKK -428,771.
About Save Stemcell Center ApS
Save Stemcell Center ApS is a Danish company of the type Anpartsselskab based in Slagelse, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Louise Camilla Zielinski. The company is owned by STORKEREDEN ApS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK -25,469 and a net result of DKK -25,544 compared with DKK -158,178 the year before. Equity in the 2025 report amounted to DKK -766,429.